Matthew Benedict Clements

Matthew Clements practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Matthew Clements' NPI, 1700204534, was assigned on March 29, 2014. Matthew Clements holds Massachusetts license 292300.

Matthew Clements' primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Matthew Clements' primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Matthew Clements is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Matthew Clements to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Clements practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Matthew Clements' primary specialty in the NPI Registry, under taxonomy code 208800000X. Matthew Clements is licensed in Massachusetts.

CMS data shows 741 Medicare services from Matthew Clements across 13 procedure codes in 2024, for 355 Medicare patients. Medicare paid $58,511 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 355 Medicare patients who saw Matthew Clements in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Clements' median patient age at 74, with 29% women.

In 2024, Matthew Clements wrote 552 Medicare Part D claims for 161 patients. 89% of them were for generic drugs. CMS names the drug for 477 of them, across 10 drugs with 11 or more claims each, at $43,986 in total drug cost. In 2023, CMS named 278 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Matthew Clements for performance year 2024, reported through an alternative payment model (APM). Matthew Clements accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Clements as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Matthew Clements, published from 2014 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Robotic Surgical Procedures. Matthew Clements has published most often in J Urol. Matthew Clements' most frequent co-authors are Tracey L. Krupski, MD, Vincent P. Laudone, MD and Noah Seth Schenkman, MD.

CMS Open Payments shows 6 general payments to Matthew Clements from 2 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $387.